Adapalene potentiates the cytotoxicity of anti-cancer drugs by enhancing cell cycle dysregulation and apoptosis in MKN-45 cells. [PDF]
Toxicol Res (Camb)Yuan TM, Liu BH, Huang YC, Chuang SM.
europepmc +1 more source
The Hidden Culprit Unraveled by Dermoscopy: A Rare Case of Pediatric Facial Demodicosis. [PDF]
CureusBouhamdi C +4 more
europepmc +1 more source
Acne Management in an Immunosuppressed Renal Transplant Patient: A Case Report. [PDF]
CureusVelázquez Arenas L +2 more
europepmc +1 more source
Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies. [PDF]
Cancers (Basel)Singla RK, Bishayee A.
europepmc +1 more source
Therapeutic potential of Licochalcone A in dermatological diseases: from basic to clinical research. [PDF]
Front PharmacolLiu D +5 more
europepmc +1 more source
The Role of Dermocosmetics in Acne Management: Implications for Clinical Practice in Brazil. [PDF]
Clin Cosmet Investig DermatolRocha MAD +5 more
europepmc +1 more source
Comparative efficacy of clindamycin phosphate with benzoyl peroxide versus clindamycin phosphate with adapalene in acne vulgaris: a systematic review and meta-analysis. [PDF]
Sci RepAleid A +11 more
europepmc +1 more source
Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity. [PDF]
Dermatol Ther (Heidelb)Gold M +5 more
europepmc +1 more source
Development of Physiologically Based Pharmacokinetic (PBPK) Modeling. [PDF]
PharmaceuticsSánchez-Dengra B, González-Álvarez I.
europepmc +1 more source
Efficacy and Safety of Fixed-dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Black Participants with Moderate to Severe Acne. [PDF]
J Clin Aesthet DermatolCallender VD +6 more
europepmc +1 more source